Literature DB >> 2153067

Spontaneous mutation in familial adenomatous polyposis.

R B Rustin1, D G Jagelman, E McGannon, V W Fazio, I C Lavery, F L Weakley.   

Abstract

A retrospective review of the familial adenomatous polyposis registry at the Cleveland Clinic Foundation revealed an incidence of spontaneous mutation in familial adenomatous polyposis (FAP) of 22 percent of family kindreds. These patients were reviewed retrospectively and compared with the total FAP population followed at The Cleveland Clinic Foundation with respect to the onset of disease, the incidence of carcinoma in the resected colon, and incidence of extracolonic manifestations. Review of the characteristics and presentations of these patients suggested that these individuals may harbor a more severe form of FAP. This may be due, in part, to the delay in diagnosis and, therefore, a higher rate of development of colorectal carcinoma and possibly duodenal adenomas. There is also a demonstrable higher rate of extracolonic manifestations of FAP present in this subset of patients. When selecting the initial type of prophylactic colonic resection the surgeon should bear in mind the increased incidence of extracolonic manifestations of the disease in this group of patients and their potential for complications.

Entities:  

Mesh:

Year:  1990        PMID: 2153067     DOI: 10.1007/bf02053203

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  14 in total

1.  Screening for familial adenomatous polyposis.

Authors:  W Hyer; J M Fell
Journal:  Arch Dis Child       Date:  2001-05       Impact factor: 3.791

2.  Determining the frequency of de novo germline mutations in DNA mismatch repair genes.

Authors:  Aung Ko Win; Mark A Jenkins; Daniel D Buchanan; Mark Clendenning; Joanne P Young; Graham G Giles; Jack Goldblatt; Barbara A Leggett; John L Hopper; Stephen N Thibodeau; Noralane M Lindor
Journal:  J Med Genet       Date:  2011-06-02       Impact factor: 6.318

3.  Risk estimation in familial adenomatous polyposis using DNA probes linked to the familial adenomatous polyposis gene.

Authors:  D J Koorey; G W McCaughan; R J Trent; N D Gallagher
Journal:  Gut       Date:  1992-04       Impact factor: 23.059

Review 4.  Lower gastrointestinal tract cancer predisposition syndromes.

Authors:  Neel B Shah; Noralane M Lindor
Journal:  Hematol Oncol Clin North Am       Date:  2010-12       Impact factor: 3.722

Review 5.  Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen.

Authors:  Nicole E Lopez; Carrie Y Peterson
Journal:  Clin Colon Rectal Surg       Date:  2016-09

6.  A comparison of the phenotype and genotype in adenomatous polyposis patients with and without a family history.

Authors:  Brindusa Truta; Brian A Allen; Peggy G Conrad; Vivian Weinberg; Glenn A Miller; Rob Pomponio; Lara R Lipton; Germano Guerra; Ian P M Tomlinson; Marvin H Sleisenger; Young S Kim; Jonathan P Terdiman
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

7.  Evaluation of molecular genetic diagnosis in the management of familial adenomatous polyposis coli: a population based study.

Authors:  E R Maher; D E Barton; R Slatter; D J Koch; M H Jones; H Nagase; S J Payne; S J Charles; A T Moore; Y Nakamura
Journal:  J Med Genet       Date:  1993-08       Impact factor: 6.318

8.  Rectal cancers in patients with familial adenomatous polyposis.

Authors:  Jennifer Liang; James M Church
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

9.  Gonadal mosaicism and familial adenomatous polyposis.

Authors:  Angela L Schwab; Thérèse M F Tuohy; Michelle Condie; Deborah W Neklason; Randall W Burt
Journal:  Fam Cancer       Date:  2007-11-18       Impact factor: 2.375

10.  Identification of patients at risk for hereditary colorectal cancer.

Authors:  Nitin Mishra; Jason Hall
Journal:  Clin Colon Rectal Surg       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.